This analysis sought to confirm the specific upregulation of CHEK1 and PLK1 in TNBC, as suggested by the initial microarray findings and cross-platform verification analysis, and to contextualize their expression within the broader landscape of breast cancer subtypes. Here, CHEK1 is linked to breast carcinoma.